Biomea Fusion, Inc.
Biomea Fusion, Inc., a biopharmaceutical company, focuses on the discovery and development of covalent small molecule drugs to treat patients with genetically defined cancers and metabolic diseases. Its lead product candidate is BMF-219, an orally bioava…
Biotechnology
US, Redwood City [HQ]
Revenue Breakdowns
Segment Analysis Beta
The financial segments are sourced from the SEC' 10-K statement.Revenue By Top Segments
Biomea Fusion, Inc. can't present it's sankey chart.
Historical Revenue By Segment
Last 3Y, in million USDBiomea Fusion, Inc. can't present revenue by segment